IP Library Granted Patent US 11,634,507
Granted Patent B2
US 11,634,507 · App. 16/838,798 · Granted Apr 25, 2023

Dendritic gold nanoparticles and methods of synthesis

Inventors: Chuanbin Mao (Norman, OK); Lin Wang (Norman, OK); Penghe Qiu (Norman, OK)
Assignee: The Board of Regents of the University of Oklahoma
C07K17/14A61K39/0011A61K39/385A61K39/39A61K2039/55561A61K2039/60A61K2039/627A61K2039/645
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,634,507
App. No.
16/838,798
Granted
Apr 25, 2023
Kind
B2
Abstract

A method of producing dendritic gold nanoparticles by combining a gold precursor solution, a reducing agent, and a bifunctional peptide having an amine-rich amino acid sequence into a buffered aqueous solution in a single container, and agitating the mixture causing the formation of the dendritic gold nanoparticles having a surface with a positive charge and a second end portion of the bifunctional peptide exposed on the surface of the dendritic gold nanoparticles. The dendritic gold nanoparticles may be used to deliver therapeutic, diagnostic, and/or immunogenic amino acid sequences as portions of the bifunctional peptide.

Claims (10)

1. A method of producing dendritic gold nanoparticles, comprising:

providing a gold precursor solution, a reducing agent, and a bifunctional peptide, wherein the bifunctional peptide comprises a first end portion comprising an amine-rich amino acid sequence, and a second end portion;

combining, in a single container, the gold precursor solution, reducing agent, and bifunctional peptide in a buffered aqueous solution at a pH in a range of 6-9 to form a mixture; and

agitating the mixture causing the formation of dendritic gold nanoparticles having a surface with a positive charge and having the second end portion of the bifunctional peptide exposed on the surface of the dendritic gold nanoparticles.

2. The method of claim 1 , wherein the first end portion of the bifunctional peptide comprises 2 to 16 positively-charged amino acids.

3. The method of claim 2 , wherein the 2 to 16 positively-charged amino acids are selected from the group consisting of arginine (R), lysine (K), and histidine (H).

4. The method of claim 1 , wherein the first end portion of the bifunctional peptide comprises the amino acid sequence X 1 -X 2 -X 3 -X 4 -X 5 -X 6 -X 7 -X 8 (SEQ ID NO:53), wherein each of X 1 -X 8 is independently selected from R, K, and H in any arrangement.

5. The method of claim 1 , wherein the first end portion and the second end portion of the bifunctional peptide are directly linked via a peptide bond.

6. The method of claim 1 , wherein the first end portion and the second end portion of the bifunctional peptide are linked together via an intervening linker sequence.

7. The method of claim 1 , comprising coating the dendritic gold nanoparticles with a negatively-charged oligodeoxynucleotide, wherein the oligodeoxynucleotide is bound electrostatically to the dendritic gold nanoparticles.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 2, 2022
From: UNIVERSITY OF OKLAHOMA
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 061375/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2020
From: MAO, CHUANBIN; WANG, LIN; QIU, PENGHE
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
Reel/Frame 052302/0257 →
Continuity (2)
Provisional Application 62831613 · Apr 9, 2019
Related Publication 20210189012A1 · Jun 24, 2021